Loading markets…

Royalty Pharma plc (RPRX) forecast

Royalty Pharma plc (RPRX) forecast: price $63.45, trailing P/E 25.78, forward P/E 11.92. How to read the street's path.

$63.45Price
$28.25BMarket cap
25.78P/E ?
11.92Forward P/E ?
1.49%Dividend yield ?

The live RPRX price is $63.45. Trailing P/E is 25.78 and forward P/E is 11.92. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the RPRX forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full RPRX quote · Dividends · Price prediction · Academy

Questions

What is RPRX's forward P/E?

The latest forward P/E on Stocklytics is 11.92, against a trailing P/E of 25.78 and a price of $63.45.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.